Technical Change and Firm Size
The Pharmaceutical Industry
Bibliographic Data
| ID | 19313314 |
|---|---|
| Authors | John M Vernon, Peter Gusen |
| Year | 1974 |
| Volume | 56 |
| Issue | 3 |
| Pages | 294 |
| Publication date | 1974-08-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | The Review of Economics and Statistics (JOURNAL) |
| Journal identifiers | ISSN: 0034-6535 • E-ISSN: 1530-9142 |
| Publisher | JSTOR (PUBLISHER) |
| DOI | 10.2307/1923966 |
| OpenAlex | W2045304522 |
| Language | EN |
| Citations received | 2 |
| References cited | 10 |
FISHER and TEMIN (1973) have argued recently that many empirical studies1 re-lating to the Schumpeterian hypothesis are in-appropriate for testing that hypothesis. They
Business · Economics · Industrial organization · Pharmaceutical industry · Economic Growth and Productivity · Innovation and Knowledge Management · Intellectual Property and Patents · Medicine · Pharmacology
Estimation of Relationships for Limited Dependent Variables
Multicollinearity in Regression Analysis
Research and Technical Change in the Pharmaceutical Industry
Industrial Research and the New Competition
Bigness, Fewness, and Research
Returns to Scale in Research and Development
An Evaluation of Consumer Protection Legislation
Research and Development Costs and Returns
Industrial Research and Development Expenditures
| Unique citing works | 2 |
|---|---|
| Citations per year | 0.05 |
| Citation span | 1983 - 2019 (37) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 2 |